M&A boom — AI enters deals
U.S. M&A activity is surging into a 'trillion‑dollar' wave and AI is being used from target ID to integration — deals are speeding up and due diligence is changing. Big healthcare consolidation continues, highlighted by Sutter Health’s planned acquisition of Allina Health to create a roughly $26B system. ( )
Sutter and Allina signed a Letter of Intent on March 17, 2026 that would make Allina the “Upper Midwest Division” of Sutter while keeping the Allina name, regional headquarters in Minneapolis, and Lisa Shannon as the regional CEO under Sutter’s Warner Thomas. (vitals.sutterhealth.org) (sutterhealth.org) The proposed combination would span 39 hospital campuses, more than 400 primary and specialty care sites, align roughly 18,000 physicians and employ about 88,000 people, with the partners citing combined 2025 revenue of about $26 billion and Sutter’s standalone 2025 revenue at roughly $19.8 billion. (healthcaredive.com) Sutter pledged more than $2 billion for investments in Minnesota and western Wisconsin aimed at establishing new ambulatory and specialty sites, accelerating clinician recruitment and upgrading AI and digital tools to reduce administrative burden. (vitals.sutterhealth.org) (sutterhealth.org) The organizations said they will complete due diligence and finalize terms “over the coming weeks and months,” targeting a close before the end of 2026 but noting the transaction is subject to regulatory approval as Minnesota authorities examine whether the structure qualifies as a merger. (healthcaredive.com) Dealmakers are explicitly framing the tie-up around tech: Sutter cited Northern California AI and platform capabilities and Allina’s Minnesota med‑tech strengths as a reason the combined system could “be a national leader in digital and technological advancements.” (vitals.sutterhealth.org) (sutterhealth.org) Industry coverage and legal commentary note a broader M&A trend of embedding AI across sourcing, valuation, due diligence, drafting and integration, while flagging governance and risk-allocation questions about AI outputs and vendor tools that parties must address in definitive agreements. (forbes.com)
